Jun Lin Ho

Jun Lin Ho

General Counsel bei SCHOLAR ROCK HOLDING CORPORATION

Vermögen: 2 Mio $ am 31.05.2024

45 Jahre
Health Technology
Health Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Jun Lin Ho

EinheitArt der EinheitIndustrie
Massachusetts Institute of Technology
511
College/University Finance/Rental/Leasing 511
38
Holding Company Miscellaneous Commercial Services 38
Public Company Biotechnology 30
Subsidiary Medical/Nursing Services 29
The University of Chicago Law School
14
College/University Other Consumer Services 14
Public Company Biotechnology 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Jun Lin Ho

UnternehmenSektorVerknüpfte PersonenHauptposition
CELGENE Biotechnology

Kristina Burow

Jay Backstrom

Director/Board Member

Chief Tech/Sci/R&D Officer

Biotechnology

Srini Akkaraju Akkaraju

Mark Levin

David Schenkein

Troy Cox

Katie Peng

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Corporate Officer/Principal

Investment Managers

Rob Burn

Rhonda Chicko

Portfolio Manager-Fixed Income

Comptroller/Controller/Auditor

Pharmaceuticals: Major

Mark Levin

David Schenkein

Steven Kafka

Chief Executive Officer

Corporate Officer/Principal

Director of Finance/CFO

ARIAD PHARMACEUTICALS, INC. Biotechnology

Michael Gilman

Jing Marantz

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

BIOGEN INC. Pharmaceuticals: Major

Michael Gilman

Tony Kingsley

David Hallal

Akshay Vaishnaw

Richard Brudnick

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Hallal

Jing Marantz

Catherine Hu

Mohammed Qatanani

Chief Executive Officer

Corporate Officer/Principal

Investor Relations Contact

Corporate Officer/Principal

Investment Managers

Kristina Burow

David Schenkein

Private Equity Investor

Private Equity Investor

ACCELERON PHARMA INC. Biotechnology

Jay Backstrom

Jing Marantz

Tracey Sacco

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Sales & Marketing

ATYR PHARMA, INC. Pharmaceuticals: Major

Srini Akkaraju Akkaraju

Amir Nashat

Director/Board Member

Chief Executive Officer

Pharmaceuticals: Major

Tony Kingsley

Amir Nashat

Chief Executive Officer

Director/Board Member

RECEPTOS INC Pharmaceuticals: Major

Amir Nashat

Kristina Burow

Director/Board Member

Founder

Miscellaneous Commercial Services

Tony Kingsley

Simo Kamppari

David Quiram

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

College/University

Timothy Springer

Steven Kafka

Kareem Akhtar

Raphi Schorr

Brittany Cvetanovich

Elisha Jackson

Jeffrey Flier

Simo Kamppari

Doctorate Degree

Doctorate Degree

Masters Business Admin

Undergraduate Degree

Graduate Degree

Undergraduate Degree

Corporate Officer/Principal

Masters Business Admin

Stanford University College/University

Srini Akkaraju Akkaraju

Leo Rafael Reif

Sameer Gandhi

Steven Kafka

Doctorate Degree

Doctorate Degree

Masters Business Admin

Undergraduate Degree

Investment Banks/Brokers

Ishan Sachdev

Jonathan Paul Loflin

Patrick Michael McCaney

Trading-Equity

Corporate Officer/Principal

Corporate Officer/Principal

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Nagesh Mahanthappa

Akshay Vaishnaw

Jing Marantz

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Other Consumer Services

Vinay Seth Mohta

Jinane Abounadi

Sales & Marketing

Director/Board Member

Bentley University College/University

Rhonda Chicko

Erin Moore

Graduate Degree

Graduate Degree

Boston College College/University

Mike Pellini

Tracey Sacco

Undergraduate Degree

Undergraduate Degree

Yale University College/University

Elisha Jackson

David Peloquin

Benjamin Rogers

Graduate Degree

Graduate Degree

Graduate Degree

College/University

Nagesh Mahanthappa

Neena Kadaba

Jinane Abounadi

Doctorate Degree

Doctorate Degree

Undergraduate Degree

University of California, Berkeley College/University

Timothy Springer

Michael Gilman

Amir Nashat

Kristina Burow

Gang Chen

Jing Marantz

Katie Peng

Undergraduate Degree

Doctorate Degree

Graduate Degree

Undergraduate Degree

Doctorate Degree

Masters Business Admin

Undergraduate Degree

Georgetown University College/University

Shari Loessberg

David Young

Undergraduate Degree

Graduate Degree

Miscellaneous Commercial Services

Leo Rafael Reif

Mun Tak Yang

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Leo Rafael Reif

Mark Levin

Corporate Officer/Principal

Corporate Officer/Principal

AMAG PHARMACEUTICALS, INC. Pharmaceuticals: Major

Edward Myles

Rushmie Nofsinger

Director of Finance/CFO

Public Communications Contact

Pharmaceuticals: Major

Amir Nashat

Nagesh Mahanthappa

Director/Board Member

Chief Operating Officer

Miscellaneous Commercial Services

Mark Levin

Jeffrey Flier

Director/Board Member

Director/Board Member

Investment Managers

David Schenkein

Wesley Chan

Private Equity Investor

Corporate Officer/Principal

Miscellaneous Commercial Services

Mark Levin

Mike Pellini

Corporate Officer/Principal

Director/Board Member

Investment Managers

Alexander M. Sauer-Budge

Young Kim

Analyst-Equity

Portfolio Manager-Equities

Biotechnology

Timothy Springer

Michael Gilman

Edward Myles

Tony Kingsley

Amir Nashat

Kristina Burow

David Hallal

Nagesh Mahanthappa

Akshay Vaishnaw

Jeffrey Flier

Erin Moore

Founder

Director/Board Member

Director of Finance/CFO

Chief Executive Officer

Director/Board Member

Director/Board Member

Chairman

Chief Executive Officer

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Harvard Business School College/University

Tony Kingsley

Mun Tak Yang

Ishan Sachdev

Young Kim

Hatice Hale Özsoy Biyikli

Tyler Ellis

Masters Business Admin

Masters Business Admin

Graduate Degree

Masters Business Admin

Masters Business Admin

Masters Business Admin

Biotechnology

Amir Nashat

Nagesh Mahanthappa

Director/Board Member

Director/Board Member

Investment Managers

Timothy Heidel

Libby Wayman

Consultant / Advisor

Private Equity Investor

Biotechnology

Amir Nashat

Kristina Burow

Director/Board Member

Director/Board Member

DENALI THERAPEUTICS INC. Biotechnology

David Schenkein

Katie Peng

Director/Board Member

Corporate Officer/Principal

PRIME MEDICINE, INC. Biotechnology

David Schenkein

Richard Brudnick

Director/Board Member

Corporate Officer/Principal

EDITAS MEDICINE, INC. Biotechnology

Akshay Vaishnaw

Rhonda Chicko

Director/Board Member

Corporate Officer/Principal

BLUEPRINT MEDICINES CORPORATION Biotechnology

Mark Levin

David Schenkein

Chairman

Director/Board Member

Biotechnology

Kristina Burow

Steven Kafka

Director/Board Member

Director/Board Member

The Leonard N Stern School of Business College/University

Catherine Hu

Tracey Sacco

Undergraduate Degree

Masters Business Admin

The Wharton School of the University of Pennsylvania College/University

Ji Zhang

Tian Hang Hu

Masters Business Admin

Masters Business Admin

METACRINE, INC. Biotechnology

Amir Nashat

Kristina Burow

Director/Board Member

Director/Board Member

Investment Managers

Mark Levin

Steven Kafka

Private Equity Investor

Corporate Officer/Principal

Pharmaceuticals: Major

Srini Akkaraju Akkaraju

Amir Nashat

Director/Board Member

Chairman

Biotechnology

Kristina Burow

David Schenkein

Director/Board Member

Director/Board Member

SYROS PHARMACEUTICALS, INC. Biotechnology

Srini Akkaraju Akkaraju

Amir Nashat

Director/Board Member

Director/Board Member

Statistik

International

Vereinigte Staaten 50

Sektoral

Health Technology 26
Consumer Services 13
Finance 8
Commercial Services 6

Operativ

Director/Board Member 423
Corporate Officer/Principal 199
Independent Dir/Board Member 100
Undergraduate Degree 94
Graduate Degree 73
  1. Börse
  2. Insiders
  3. Jun Lin Ho
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT